Phase IIb trial of BTI 320 [PAZ 320] in patients with type 2 diabetes mellitus treated with metformin in USA
Phase of Trial: Phase II
Latest Information Update: 09 Oct 2014
Price : $35 *
At a glance
- Drugs BTI 320 (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Boston Therapeutics
- 09 Oct 2014 Results published in the Media Release.
- 09 Oct 2014 Status changed from not yet recruiting to completed, according to a Boston Therapeutics media release.
- 05 Mar 2014 New trial record